Naylor Stuart

CHIEF SCI OFCR, OPHTHALMOLOGY at MGTX

Sold, on record
$2.2M
Dollars the filings state
Form 4 sales
15
Latest Jul 7, 2026
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

  • MGTXMeiraGTx Holdings plcCHIEF SCI OFCR, OPHTHALMOLOGY

Sales by reason

2
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale MGTXPlan not stated
    Jan 5 2021

    Sold 12,000 shares at $15.37 ($184k)

    Naylor Stuart, Chief Development Officer

    Sold 2.7% of holdings ($6.9M position)438,017 shares left1.4x usual sizeFiling

  2. 2 Form 4 sale MGTXPlan not stated
    Apr 29 +114 days

    Sold 5,177 shares at $15.11 ($78k)

    Naylor Stuart, Chief Development Officer

    Sold 1.2% of holdings ($6.6M position)432,840 shares left0.5x usual sizeFiling

  3. 3 Form 4 sale MGTXPlan not stated
    Jun 8 +40 days

    Sold 6,082 shares at $15.01 ($91k)

    Naylor Stuart, Chief Development Officer

    Sold 1.4% of holdings ($6.5M position)426,017 shares left0.7x usual sizeFiling

  4. 4 Form 4 sale MGTXPlan not stated
    Jul 13 +35 days

    Sold 2,610 shares at $15.04 ($39k)

    Naylor Stuart, Chief Development Officer

    Sold 0.6% of holdings ($6.4M position)423,407 shares left0.4x usual sizeFiling

  5. 5 Form 4 sale MGTXPlan not stated
    Jul 20 +7 days

    Sold 9,390 shares at $15.06 ($141k)

    Naylor Stuart, Chief Development Officer

    Sold 2.2% of holdings ($6.4M position)414,017 shares left1.5x usual sizeFiling

  6. 6 Form 4 sale MGTXPlan not stated
    Oct 18 +90 days

    Sold 12,000 shares at $17.95 ($215k)

    Naylor Stuart, Chief Development Officer

    Sold 2.9% of holdings ($7.4M position)402,017 shares left1.6x usual sizeFiling

  7. 7 Form 4 sale MGTXRoutine
    Apr 7 +1632 days

    Sold 27,661 shares at $9.36 ($259k)

    Naylor Stuart, CHIEF DEV. OFFICER

    10b5-1 planSold 4% of holdings ($6.5M position)668,505 shares leftFirst sale on recordFiling

  8. 8 Form 4 sale MGTXRoutine
    Jul 7 +91 days

    Sold 27,659 shares at $14.80 ($409k)

    Naylor Stuart, CHIEF SCI OFCR, OPHTHALMOLOGY

    10b5-1 planSold 4.1% of holdings ($9.9M position)640,846 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (15)

Form 144 notices and Form 4 sales by Naylor Stuart
Source
Jul 7, 2026MGTXCHIEF SCI OFCR, OPHTHALMOLOGYForm 4 sale27,659$409k4.1%RoutineSEC
Apr 7, 2026MGTXCHIEF DEV. OFFICERForm 4 sale27,661$259k4.0%RoutineSEC
Oct 18, 2021MGTXChief Development OfficerForm 4 sale12,000$215k2.9%Plan not statedSEC
Jul 20, 2021MGTXChief Development OfficerForm 4 sale9,390$141k2.2%Plan not statedSEC
Jul 13, 2021MGTXChief Development OfficerForm 4 sale2,610$39k0.6%Plan not statedSEC
Jun 8, 2021MGTXChief Development OfficerForm 4 sale6,082$91k1.4%Plan not statedSEC
Apr 29, 2021MGTXChief Development OfficerForm 4 sale5,177$78k1.2%Plan not statedSEC
Jan 5, 2021MGTXChief Development OfficerForm 4 sale12,000$184k2.7%Plan not statedSEC
Nov 10, 2020MGTXChief Development OfficerForm 4 sale3,739$56k0.8%Plan not statedSEC
Nov 9, 2020MGTXChief Development OfficerForm 4 sale8,794$132k1.9%Plan not statedSEC
Oct 5, 2020MGTXChief Development OfficerForm 4 sale301$5k0.1%Plan not statedSEC
Jul 21, 2020MGTXChief Development OfficerForm 4 sale10,054$151k2.1%Plan not statedSEC
May 11, 2020MGTXChief Development OfficerForm 4 sale11,304$174k2.3%Plan not statedSEC
Apr 20, 2020MGTXChief Development OfficerForm 4 sale696$10k0.1%Plan not statedSEC
Feb 19, 2020MGTXChief Development OfficerForm 4 sale12,000$216k2.4%Plan not statedSEC